Indication

Neuroblastoma

Neuroblastoma is a malignant embryonal malignancy of the peripheral sympathetic nervous system that arises from immature nerve cells known as neuroblasts. Read more about Neuroblastoma

65 drugs 51 manufacturers

Advertisement

Drugs that treat it

Common Neuroblastoma therapies.

Showing 64–65 of 65 drugs

CYCLOPHOSPHAMIDE

NITROGEN MUSTARD DERIVATIVES·RETINOBLASTOMA·+17
OPKO PHARMACEUT
Filter & compare in the drug finder →Opens the drug finder with Neuroblastoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Neuroblastoma.

Neuroblastoma is a malignant embryonal malignancy of the peripheral sympathetic nervous system that arises from immature nerve cells known as neuroblasts.

It primarily affects infants and young children, most commonly occurring under five years of age.

The disease most frequently originates in the adrenal medulla or along the paraspinal sympathetic chain in the abdomen, chest, neck, or pelvis.

Clinically, neuroblastoma exhibits extreme biological heterogeneity, ranging from asymptomatic localized tumors that may spontaneously regress to aggressive, widely metastatic disease commonly involving the bone marrow, skeleton, liver, and distant lymph nodes.

Personalize your experience

Follow Neuroblastoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it